Pittaluga A
Br J Pharmacol. 2020; 178(5):1001-1017.
PMID: 33347605
PMC: 9328659.
DOI: 10.1111/bph.15349.
Adrover M, Shin J, Quiroz C, Ferre S, Lemos J, Alvarez V
J Neurosci. 2020; 40(39):7510-7522.
PMID: 32859717
PMC: 7511190.
DOI: 10.1523/JNEUROSCI.1327-20.2020.
Nolan S, Zachry J, Johnson A, Brady L, Siciliano C, Calipari E
J Neurochem. 2020; 155(5):475-493.
PMID: 32356315
PMC: 7606645.
DOI: 10.1111/jnc.15034.
Yuan L, Dou Y, Sun Y
J Neurosci. 2019; 39(33):6472-6481.
PMID: 31217328
PMC: 6697397.
DOI: 10.1523/JNEUROSCI.0271-19.2019.
Herrera-Marschitz M, Meana J, OConnor W, Goiny M, Reid M, Ungerstedt U
Amino Acids. 2013; 2(1-2):157-79.
PMID: 24194283
DOI: 10.1007/BF00806086.
Simultaneous determination of cholecystokinin, dopamine, glutamate and aspartate in cortex and striatum of the rat using in vivo microdialysis.
Meana J, Herrera-Marschitz M, Brodin E, Hokfelt T, Ungerstedt U
Amino Acids. 2013; 1(3):365-73.
PMID: 24194176
DOI: 10.1007/BF00814005.
Role of excitatory amino acids in the direct and indirect presynaptic regulation of dopamine release from nerve terminals of nigrostriatal dopaminergic neurons.
Cheramy A, Kemel M, Gauchy C, Desce J, GALLI T, Barbeito L
Amino Acids. 2013; 1(3):351-63.
PMID: 24194175
DOI: 10.1007/BF00814004.
Further contribution to the study of corticostriatal glutamatergic and nigrostriatal dopaminergic interactions within the striatal network: an in vivo voltammetric investigation.
Forni C, Dusticier N, Nieoullon A
Amino Acids. 2013; 3(1):53-68.
PMID: 24192989
DOI: 10.1007/BF00806008.
Functional reactivity of the dopaminergic system following acute and chronic ketamine treatments.
Owolabi A, Akanmu M, Ukponmwan O
Naunyn Schmiedebergs Arch Pharmacol. 2008; 378(1):117-24.
PMID: 18408917
DOI: 10.1007/s00210-008-0283-x.
Alterations in NMDA receptor subunit levels in the brain regions of rats chronically administered typical or atypical antipsychotic drugs.
Hanaoka T, Toyoda H, Mizuno T, Kikuyama H, Morimoto K, Takahata R
Neurochem Res. 2003; 28(6):919-24.
PMID: 12718446
DOI: 10.1023/a:1023231611616.
The effects of stress on central dopaminergic neurons: possible clinical implications.
FINLAY J, Zigmond M
Neurochem Res. 1997; 22(11):1387-94.
PMID: 9355111
DOI: 10.1023/a:1022075324164.
Effect of antipsychotic drugs on the gene expression of NMDA receptor subunits in rats.
Toyoda H, Takahata R, Inayama Y, Sakai J, Matsumura H, Yoneda H
Neurochem Res. 1997; 22(3):249-52.
PMID: 9051657
DOI: 10.1023/a:1022426402611.
In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids.
Keefe K, Zigmond M, Abercrombie E
J Neural Transm Gen Sect. 1993; 91(2-3):223-40.
PMID: 8099798
DOI: 10.1007/BF01245233.
Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease.
Deutch A
J Neural Transm Gen Sect. 1993; 91(2-3):197-221.
PMID: 8099797
DOI: 10.1007/BF01245232.
Effects of kainic acid, quisqualic acid, and their antagonist, pCB-PzDA, on rat electrocorticograms and monoamine metabolite levels in rat striatum.
Kabuto H, Yokoi I, MoonSuk S, Yamamoto M, Mori A
Neurochem Res. 1994; 19(3):267-74.
PMID: 7513829
DOI: 10.1007/BF00971574.
Interneurones are probably not involved in the presynaptic dopaminergic control of dopamine release in rabbit caudate nucleus.
Jackisch R, Zumstein A, Hertting G, Starke K
Naunyn Schmiedebergs Arch Pharmacol. 1980; 314(2):129-33.
PMID: 7453832
DOI: 10.1007/BF00504528.
Effects of kainic acid on body temperature of rats: role of catecholaminergic and serotonergic systems.
Turski L, Kleinrok Z
Psychopharmacology (Berl). 1980; 71(1):35-9.
PMID: 6779322
DOI: 10.1007/BF00433249.
[Biosynthesis of amino acids from glucose in the central nervous system in the Parkinson syndrome].
GRUNDIG E, Mayer W, Gerstenbrand F
Arch Psychiatr Nervenkr (1970). 1983; 233(5):397-408.
PMID: 6651503
DOI: 10.1007/BF00346090.
GABA in the thalamic motor nuclei modulates dopamine release from the two dopaminergic nigrostriatal pathways in the cat.
Chesselet M, Cheramy A, Romo R, Desban M, Glowinski J
Exp Brain Res. 1983; 51(2):275-82.
PMID: 6617796
DOI: 10.1007/BF00237203.
Motor effects following application of putative excitatory amino acid antagonists to the region of the mesencephalic dopamine cell bodies in the rat.
Dawbarn D, Pycock C
Naunyn Schmiedebergs Arch Pharmacol. 1981; 318(2):100-4.
PMID: 6120471
DOI: 10.1007/BF00508833.
